Antibiotics are designed to wipe out infection-causing bacteria, but even a single course can leave a lasting mark on the gut microbiome, according to a new study of nearly 15,000 adults in Sweden.

The gut microbiome—the trillions of bacteria and other microbes that inhabit the gastrointestinal tract—drives a process vital for protecting the colon against tissue injury, according to the findings ...

Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections Qualified Infectious Disease ...

Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections -- Qualified Infectious ...

CARB-X announced today that it’s awarding $1.2 million to a research team at Harvard University to develop enhanced antibiotics for multidrug-resistant bacteria.

We often hear about bacteria, but what exactly are they? A bacterium is a living organism that consists of a single cell (unicellular). It has ...

BRD is often framed as stress, viruses and bacteria. Managing inflammation tied to endotoxin helps explain why some cattle recover faster than others ...

Using genetic sequencing, researchers from Denmark and Australia studied the gut bacteria of cancer patients in a large study and found that Bacteroides fragilis produces a toxin (BFT) in the colon, ...

CARB-X is looking to fund projects focused on gram-negative bacteria, novel chemistry, and non-vaccine approaches for ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, February 25, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to ...

-- First of two Pivotal Efficacy Studies support future sNDA submission for Treatment of Pulmonary Anthrax -- Oral NUZYRA Tablets Produced in the U.S. as a Result of the Company's Onshoring Initiative ...

First of two Pivotal Efficacy Studies support future sNDA submission for Treatment of Pulmonary AnthraxOral NUZYRA Tablets Produced in the U.S.